{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:14:48Z","timestamp":1794244488046,"version":"4.9.0"},"reference-count":51,"publisher":"Informa UK Limited","issue":"1-2","license":[{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/21678421.2024.2375330","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T01:11:10Z","timestamp":1720401070000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Treatment continuity of amyotrophic lateral sclerosis with available riluzole formulations: state of the art and current challenges in a \u2018real-world\u2019 setting"],"prefix":"10.1080","volume":"26","author":[{"given":"Philippe","family":"Corcia","sequence":"first","affiliation":[{"name":"CHRU Bretonneau, Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Guy","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, CHU de Clermont-Ferrand; Inserm Neuro-Dol U1107, Universit\u00e9 Clermont Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Pradat","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re APHP, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Soriani","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, CHU de Nice, H\u00f4pital Pasteur 2, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9062","authenticated-orcid":false,"given":"Annie","family":"Verschueren","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, H\u00f4pital de la Timone, Marseille, France, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Couratier","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,7]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00414-2"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207474"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01272-7"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14393"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.262578"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00465-8"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117054"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2022.2053722"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00612-2"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111523"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16264"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1738390"},{"key":"e_1_3_3_14_1","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller RG","year":"2012","unstructured":"Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;2012:CD001447.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2020.1771734"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00094"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2023.2245860"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S123776"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1168"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20057775"},{"key":"e_1_3_3_21_1","first-page":"CD006049","article-title":"Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis\/motor neuron disease","volume":"1","author":"Diana A","year":"2017","unstructured":"Diana A, Pillai R, Bongioanni P, O'Keeffe AG, Miller RG, Moore DH. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev. 2017;1:CD006049.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135351"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.695379"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300901"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/146608202317576507"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S135748"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00246"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30054-1"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00442"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312908"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/146608201753275508"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27541"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09919-9"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1299-1"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6522"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-000763"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116650"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2223949"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10315-2"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00104-0"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27244"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10346-9"},{"key":"e_1_3_3_44_1","unstructured":"Food and Drug Administration. Guidance for Industry. Tablet Scoring: Nomenclature Labeling and Data for Evaluation. March 2013 http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm Access on December 14 2023."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb05630.x"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.09.016"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S150550"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49424-3"},{"key":"e_1_3_3_49_1","first-page":"101","article-title":"Randomised, 2-sequence, 4-period replicate cross-over bioequivalence study of a new riluzole orodispersible film vs. a reference tablet in healthy volunteers","volume":"8","author":"Di Stefano AFD","year":"2022","unstructured":"Di Stefano AFD, Radicioni MM, Segantin A, Gentili A, Baroglio C, Marjanovic I, et\u00a0al. Randomised, 2-sequence, 4-period replicate cross-over bioequivalence study of a new riluzole orodispersible film vs. a reference tablet in healthy volunteers. J Bioeq Stud 2022;8:101.","journal-title":"J Bioeq Stud"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.747"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-015-9686-2"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/hex.12169"}],"container-title":["Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21678421.2024.2375330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T08:00:38Z","timestamp":1737014438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21678421.2024.2375330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/21678421.2024.2375330"],"URL":"https:\/\/doi.org\/10.1080\/21678421.2024.2375330","relation":{},"ISSN":["2167-8421","2167-9223"],"issn-type":[{"value":"2167-8421","type":"print"},{"value":"2167-9223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iafd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}